Pesquisas alternativas:
developed ptypei » developed paper (Expandir a Pesquisa), developed aptamer (Expandir a Pesquisa), developed open (Expandir a Pesquisa)
developed phase » development phase (Expandir a Pesquisa), developed plasma (Expandir a Pesquisa), developing phase (Expandir a Pesquisa)
doses develop » loss develop (Expandir a Pesquisa), posters develop (Expandir a Pesquisa), models develop (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 35 para a pesquisa '(( drug de ((developed ptypei) OR (developed phase)) ) or ( drug doses develop type ))', tempo de pesquisa: 1.77seg Refinar resultados
Analysis of Drug Development Paradigms for Immune Checkpoint inhibitors
Dose‐Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis

Planejamento, síntese e avaliação farmacológica de uma nova série de derivados cicloalquil-N-Acilidrazonas : análogos de LASSBio-294 /
Caracterização química e atividade antitumoral in vitro de tinturas de Viscum album L. /

Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy

MEK1/2 Inhibition in Murine Heart and Aorta After Oral Administration of Refametinib Supplemented Drinking Water
The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase-8-dependent pathway

STatistically Assigned Response Criteria in Solid Tumors (STARCIST)
Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections.

THER-22. BROMODOMAIN INHIBITORS INDUCE DOWNREGULATION OF DNA DAMAGE REPAIR PATHWAYS AND OFFER NOVEL SYNERGISTIC COMBINATIONS WITH ENHANCED SAFETY PROFILES FOR THE TREATMENT OF MEDULLOBLASTOMA AND GLIOBLASTOMA
Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data

Multi-component infusion hepatoprotectors for liver damage
Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium

Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study
A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability

Manejo perioperatorio de pacientes con patología tiroidea y tratamiento crónico con corticoides
Efficacy and Safety of Fosmidomycin–Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon

36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016
Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa